Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 4812

1.

[Results of preoperative embolization of portal vein in patients with biliary hepatic tumors].

Kotenko OG, Kondratiuk VA, Fedorov DA, Grinenko AV, Korshak AA, Gusev AV, Popov AO, Grigorian MS.

Klin Khir. 2014 Nov;(11):5-7. Russian.

PMID:
25675733
2.

[How to do: Radiofrequency thermal ablation].

Schulthei├č M, Thimme R.

Dtsch Med Wochenschr. 2015 Jan;140(1):36-8. doi: 10.1055/s-0040-100416. Epub 2015 Jan 12. German. No abstract available.

PMID:
25580971
3.

Outcomes of hepatic resection for large hepatocellular carcinoma: special reference to postoperative recurrence.

Tanaka S, Iimuro Y, Hirano T, Hai S, Suzumura K, Fujimoto J.

Am Surg. 2015 Jan;81(1):64-73.

PMID:
25569068
4.

Intermittent hepatic inflow occlusion during partial hepatectomy for hepatocellular carcinoma does not shorten overall survival or increase the likelihood of tumor recurrence.

Huang J, Tang W, Hernandez-Alejandro R, Bertens KA, Wu H, Liao M, Li J, Zeng Y.

Medicine (Baltimore). 2014 Dec;93(28):e288. doi: 10.1097/MD.0000000000000288.

PMID:
25526466
5.

Uncompromised treatment efficacy in elderly patients with hepatocellular carcinoma: a propensity score analysis.

Liu PH, Hsu CY, Lee YH, Hsia CY, Huang YH, Su CW, Chiou YY, Lin HC, Huo TI.

Medicine (Baltimore). 2014 Dec;93(28):e264. doi: 10.1097/MD.0000000000000264. Erratum in: Medicine (Baltimore). 2015 Jan;94(4):1.

PMID:
25526453
6.

Hepatic angiomyolipoma mimicking hepatocellular carcinoma: magnetic resonance imaging and clinical pathological characteristics in 9 cases.

Wang CP, Li HY, Wang H, Guo XD, Liu CC, Liu SH, Gao XD, Qu JH, Liu Z, Chang XJ, Lu YY, Zeng Z, Lou M, Yang YP.

Medicine (Baltimore). 2014 Dec;93(28):e194. doi: 10.1097/MD.0000000000000194. Erratum in: Medicine (Baltimore). 2015 Jan;94(2):1.

PMID:
25526436
7.

Barcelona clinic liver cancer stage B hepatocellular carcinoma: transarterial chemoembolization or hepatic resection?

Jianyong L, Lunan Y, Wentao W, Yong Z, Bo L, Tianfu W, Minqing X, Jiaying Y.

Medicine (Baltimore). 2014 Nov;93(26):e180. doi: 10.1097/MD.0000000000000180.

PMID:
25474433
8.

Long-term favorable surgical results of laparoscopic hepatic resection for hepatocellular carcinoma in patients with cirrhosis: a single-center experience over a 10-year period.

Yamashita Y, Ikeda T, Kurihara T, Yoshida Y, Takeishi K, Itoh S, Harimoto N, Kawanaka H, Shirabe K, Maehara Y.

J Am Coll Surg. 2014 Dec;219(6):1117-23. doi: 10.1016/j.jamcollsurg.2014.09.003. Epub 2014 Sep 8.

PMID:
25442066
10.
11.

Synchronous splenectomy and hepatectomy in patients with hepatocellular carcinoma, hypersplenism and liver cirrhosis.

Shi R, Zhang YM, Zhu ZJ, Deng YL, Pan C, Zheng H, Shen ZY.

Hepatogastroenterology. 2014 Jul-Aug;61(133):1363-7.

PMID:
25436312
13.

Low postoperative platelet count is associated with negative outcome after liver resection for hepatocellular carcinoma.

Riediger C, Bachmann J, Hapfelmeier A, Friess H, Kleeff J, Mueller MW.

Hepatogastroenterology. 2014 Jul-Aug;61(133):1313-20.

PMID:
25436303
15.

Multimodality treatment involving radiotherapy for advanced liver-confined hepatocellular carcinoma.

Yoon HI, Seong J.

Oncology. 2014;87 Suppl 1:90-8. doi: 10.1159/000368151. Epub 2014 Nov 22. Review.

PMID:
25427739
16.

Multimodality treatment with radiotherapy for huge hepatocellular carcinoma.

Han HJ, Kim MS, Cha J, Choi JS, Han KH, Seong J.

Oncology. 2014;87 Suppl 1:82-9. doi: 10.1159/000368150. Epub 2014 Nov 22.

PMID:
25427738
17.

Treatment strategies of intermediate-stage hepatocellular carcinomas in Japan (Barcelona Clinic Liver Cancer stage B).

Yamakado K, Kudo M.

Oncology. 2014;87 Suppl 1:78-81. doi: 10.1159/000368149. Epub 2014 Nov 22. Review.

PMID:
25427737
18.

Breakthroughs in the management of hepatocellular carcinoma: celebrating 50 years of the liver cancer study group of Japan.

Kudo M.

Oncology. 2014;87 Suppl 1:1-6. doi: 10.1159/000368140. Epub 2014 Nov 22. No abstract available.

PMID:
25427728
19.

Survival, efficacy, and safety of small versus large doxorubicin drug-eluting beads TACE chemoembolization in patients with unresectable HCC.

Prajapati HJ, Xing M, Spivey JR, Hanish SI, El-Rayes BF, Kauh JS, Chen Z, Kim HS.

AJR Am J Roentgenol. 2014 Dec;203(6):W706-14. doi: 10.2214/AJR.13.12308.

PMID:
25415737
20.

Radiofrequency ablation versus reresection in treating recurrent hepatocellular carcinoma: a meta-analysis.

Cai H, Kong W, Zhou T, Qiu Y.

Medicine (Baltimore). 2014 Nov;93(22):e122. doi: 10.1097/MD.0000000000000122.

PMID:
25396332
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk